Lumen Technologies (LUMN) had the highest return between June 1, 2024 and September 23, 2024 by a mid-cap US stock, returning 468.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Lumen Technologies (LUMN) | 6/1/2024 - 9/23/2024 | 468.75% |
Ast Spacemobile (ASTS) | 6/1/2024 - 9/23/2024 | 230.97% |
GDS (GDS) | 6/1/2024 - 9/23/2024 | 153.21% |
Verona Pharma PLC ADR (VRNA) | 6/1/2024 - 9/23/2024 | 135.29% |
LandBridge Company LLC (LB) | 6/1/2024 - 9/23/2024 | 116.42% |
PureCycle Technologies (PCTTW) | 6/1/2024 - 9/23/2024 | 111.53% |
ADMA Biologics (ADMA) | 6/1/2024 - 9/23/2024 | 107.78% |
Sezzle Inc Common Stock (SEZL) | 6/1/2024 - 9/23/2024 | 105.01% |
Polestar Automotive Holding UK PLC Class C-1 ADS (ADW) (PSNYW) | 6/1/2024 - 9/23/2024 | 100.71% |
Clear Secure (YOU) | 6/1/2024 - 9/23/2024 | 94.36% |
Polestar Automotive Holding UK PLC Class A ADS (PSNY) | 6/1/2024 - 9/23/2024 | 85.63% |
American Healthcare REIT (AHR) | 6/1/2024 - 9/23/2024 | 79.44% |
Zeta Global (ZETA) | 6/1/2024 - 9/23/2024 | 78.15% |
Rocket Lab USA (RKLB) | 6/1/2024 - 9/23/2024 | 71.82% |
Arcellx (ACLX) | 6/1/2024 - 9/23/2024 | 62.93% |
Compass (COMP) | 6/1/2024 - 9/23/2024 | 62.73% |
ICU Medical (ICUI) | 6/1/2024 - 9/23/2024 | 62.71% |
Cellebrite DI (CLBT) | 6/1/2024 - 9/23/2024 | 62.59% |
Protagonist Therapeutics (PTGX) | 6/1/2024 - 9/23/2024 | 61.82% |
Veracyte (VCYT) | 6/1/2024 - 9/23/2024 | 60.77% |
Avidity Biosciences (RNA) | 6/1/2024 - 9/23/2024 | 60.69% |
Denali Therapeutics (DNLI) | 6/1/2024 - 9/23/2024 | 59.92% |
Cinemark (CNK) | 6/1/2024 - 9/23/2024 | 59.56% |
Bancorp (TBBK) | 6/1/2024 - 9/23/2024 | 59% |
Mirum Pharmaceuticals (MIRM) | 6/1/2024 - 9/23/2024 | 58.77% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
